Accustem Sciences Inc. (ACUT)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -3.74 Million USD | -458.66% |
| 2021 | -670.61 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 833.34 Thousand USD | -99.88% |
| 2023 Q3 | -598.52 Thousand USD | -60.57% |
| 2023 Q2 | -372.75 Thousand USD | -144.73% |
| 2022 Q3 | -899.12 Thousand USD | 16.61% |
| 2022 Q2 | -1.07 Million USD | -36.39% |
| 2022 Q1 | -790.53 Thousand USD | -17.88% |
| 2022 FY | -3.74 Million USD | -458.66% |
| 2022 Q4 | 676.02 Million USD | 75286.59% |
| 2021 Q4 | -670.61 Thousand USD | 0.0% |
| 2021 FY | -670.61 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -2558.788% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -445.37% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -2084.379% |
| CytoDyn Inc. | -18.05 Million USD | 79.253% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 93.649% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -518213.111% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -106.264% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 25.732% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -12408.076% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1964.313% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Cognition Inc. | -9.7 Million USD | 61.399% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 93.251% |
| SQZ Biotechnologies Company | -75.82 Million USD | 95.059% |
| Resverlogix Corp. | -12.74 Million USD | 70.614% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -861.681% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 138.455% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -52.584% |
| Mesoblast Limited | -84.14 Million USD | 95.548% |
| GB Sciences, Inc. | -1.42 Million USD | -163.738% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -445.37% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 79.008% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -10.028% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 43.646% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -18.248% |
| ContraFect Corporation | -56.88 Million USD | 93.415% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -36.192% |
| BioStem Technologies, Inc. | -7.77 Million USD | 51.839% |
| LadRx Corporation | -3.82 Million USD | 2.019% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 76.393% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -234.801% |
| CSL Limited | 3.7 Billion USD | 100.101% |
| Biomind Labs Inc. | -1 Million USD | -271.078% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -302.244% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 104.577% |
| Nascent Biotech, Inc. | -2.22 Million USD | -68.01% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 94.781% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 176.227% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 205.831% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -143.9% |
| Marizyme, Inc. | -34.08 Million USD | 89.009% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 55.133% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -563.408% |
| Zenith Capital Corp. | -8.94 Million USD | 58.108% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -31.43% |
| Halberd Corporation | -75.05 Thousand USD | -4891.897% |
| Genus plc | 6.4 Million USD | 158.538% |
| Pharming Group N.V. | -4.87 Million USD | 23.222% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -88.596% |
| IMV Inc. | -38.67 Million USD | 90.312% |
| Affymax, Inc. | -15.04 Million USD | 75.1% |
| SYBLEU INC | -149.18 Thousand USD | -2411.341% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -258.852% |
| Enzolytics Inc. | -2.14 Million USD | -74.349% |
| argenx SE | -425.04 Million USD | 99.119% |
| AVAX Technologies, Inc. | 6.69 Million USD | 155.976% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -167.221% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -180.54% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -14784.462% |
| Cell Source, Inc. | -4.32 Million USD | 13.385% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -675.557% |
| Q BioMed Inc. | -3.44 Million USD | -8.73% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 11.608% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -198.282% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -42.584% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 17.747% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 93.185% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -29.131% |
| Rebus Holdings, Inc. | -664 Thousand USD | -464.22% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -280.713% |
| Skye Bioscience, Inc. | -13.67 Million USD | 72.597% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -100.948% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -86.876% |
| ONE Bio Corp. | 13.68 Million USD | 127.383% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -93.853% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -233.043% |
| Agentix Corp. | -1.37 Million USD | -173.111% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -28.326% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -137.212% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -21405.189% |
| Kadimastem Ltd | -3.04 Million USD | -23.227% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1331.428% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -801.711% |
| NovAccess Global Inc. | -2.46 Million USD | -51.876% |
| Itoco Inc. | -919.14 Thousand USD | -307.6% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1602.314% |
| Qrons Inc. | -643.67 Thousand USD | -482.034% |
| Mobile Lads Corp. | -554.55 Thousand USD | -575.578% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.099% |
| International Stem Cell Corporation | -663 Thousand USD | -465.071% |
| Bioxytran, Inc. | -3.82 Million USD | 1.93% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -7017.057% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -18318.972% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 89.67% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -131.546% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -409.138% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -20.425% |
| Neutra Corp. | -229.48 Thousand USD | -1532.526% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 78.639% |
| PureTech Health plc | -146.19 Million USD | 97.437% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 82.568% |
| IXICO plc | -1.43 Million USD | -160.711% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 60.527% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 96.924% |
| CSL Limited | 3.81 Billion USD | 100.098% |
| Cellectis S.A. | -108.85 Million USD | 96.558% |